 |
 |
|||
|
|
|||
|
 |
Metro New Jersey Chapter Upcoming Chapter Meetings Chapter Homepage | Prior Chapter Events Licensing
Executives Society - NJ Chapter Meeting Merck’s Got A New Attitude! Guest Speaker MERVYN J. TURNER, PhD Many of the world’s most effective drugs and vaccines have come from the laboratories of this icon of American industry, Merck & Co., Inc. For many years, Merck was successful at licensing, but relied on its reputation to generate opportunity. But as the licensing market has heated up, and faced with patent expiries and development failures, Merck has had to reinvent its licensing process to overcome perceptions of arrogance and NIH syndrome. The company is now going outside for new drugs in an aggressive manner, which is seen as essential for growth and continued success as a leader in the industry. To reverse the negative image and to encourage the scientists to treat smaller biotechs with more courtesy and respect, Dr. Mervyn Turner says, "We sent our guys to charm school." Apparently the efforts are working. In recent years, Merck has been signing 40-50 significant deals per year, a phenomenal number compared to only 10 in 1999. Join us for this exceptional meeting as one of the leaders in the pharma licensing profession talks about his company’s licensing experiences and how they have become one of the best partners of choice in the industry. ________________________________________________________________________________________ Dr. Mervyn Turner joined Merck Research Laboratories in 1985. Over the last 20 years, he has held many positions of increasing responsibility at Merck. In August 1999, Dr. Turner was appointed Senior Vice President, Merck Frosst Centre for Therapeutic Research in Montreal, Canada. Dr. Turner returned from his assignment in Montreal in October 2002 to take up his current position as Senior Vice President, Worldwide Licensing and External Research. In this role, he is responsible for the oversight of all of Merck’s licensing activities, and for the management of academic relations. Through his multiple and diverse experiences in the Merck Research Laboratories, Dr. Turner has acquired a broad perspective on the issues surrounding drug discovery and development. 2004 through 2006 saw a sizeable increase in deal activity for Merck, with over 140 transactions completed. Merck has also been active in M & A, with Aton, Abmaxis, and GlycoFi all acquired to build areas of key strategic importance. Dr. Turner sees all this activity as a logical product of a cultural shift within Merck towards a more outward-facing organization. Dr. Turner is the author of over 80 articles in peer reviewed journals. He has served on the Editorial Board of a number of journals, and since 1998 has been a member of Health Care Ventures Scientific Advisory Board. He is a member of LES. Date/Time: Location: Schedule: Dress Code: Business or Business Casual Costs and Cancellation Policies Cancellations made after 5:00pm EST, Oct. 4 cannot be reimbursed, but substitutions are welcome! Registration and Payment Options 1. If you are a member of LES, register here with your credit card; If you are NOT a member of LES, register here with your credit card; 2. To register and pay by check, send e-mail to lindawebb@definedhealth.com Include your Name, Title, Company, Phone & E-mail Address Make check payable to: LES-NJ Local Committee Mail check and your business card to: Linda Webb Dress Code: Business Casual Linda Webb and Mary Hildebrand, Co-Chairs DIRECTIONS TO BASKING RIDGE COUNTRY CLUB FROM NORTH JERSEY: FROM CENTRAL JERSEY: FROM SOUTH JERSEY: FROM POINTS WEST: FROM NEWARK AIRPORT and
NJ TURNPIKE: NEARBY HOTELS: North Maple Inn The Inn at Somerset Hills The Olde Mill Inn The Madison Hotel The Hilton at Short Hills Somerset Hills Hotel The Grand Summit Hotel |
